This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Study Type
OBSERVATIONAL
Enrollment
1,000
all enrolled patients must receive endovascular treatment.
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China
Proportion of patients with modified Rankin Score (mRS) 0 to 2
the minimum and maximum values of mRS are 0 and 6, respectively; higher mRS mean a worse outcome
Time frame: Day 90
Changes in National Institute of Health stroke scale (NIHSS)
the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome
Time frame: Day 2, 7, 14
Proportion of patients with modified Rankin Score 0 to 2
Proportion of patients with modified Rankin Score 0 to 2
Time frame: Day180, 360
Distribution of modified Rankin Score
Distribution of modified Rankin Score after treatment
Time frame: Day 90, 180, 360
Proportion of symptomatic intracranial hemorrhage (sICH)
sICH was defined as 4 or more increase in NIHSS caused by hemorrhage
Time frame: 48 hours
Proportion of intraparenchymal hemorrhage (PH1 and PH2)
Proportion of intraparenchymal hemorrhage (PH1 and PH2) after treatment
Time frame: 48 hours
Proportion of death
death due to any cause
Time frame: Day 7
Changes in cerebral edema
edema is determined by middle shift.
Time frame: 48 hours, 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.